BIO-RAD LABORATORIES, INC. — Director's Dealing 2017

Mar 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-03-02

Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-02	Bio-Rad A Common Stock	M	3500	$75.32	Acquired	61422.3998	Direct
2017-03-02	Bio-Rad A Common Stock	S	3500	$196.3396	Disposed	57922.3998	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-02	Non-Qualified Stock Option (right to buy)	$75.32	M	3500	Disposed	2017-08-01	Bio-Rad A Common Stock (3500)	Direct

Footnotes

F1: Includes 4.6707 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2016.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.306 to $196.415 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The option vested in five equal annual installments beginning on August 1, 2008.